By delivering world-leading technologies and products, alongside responsive clinical services, across the fields of prosthetics, orthotics and assistive technology, Steeper’s mission is to create turning points that empower patients and fundamentally enhance people’s lives.
Plié 3 - Stronger. Smarter. Submersible.
Stronger construction makes the new Plié 3 Microprocessor Controlled (MPC) Knee by Freedom Innovations both submersible and more rugged than ever. Yet, it’s still the fastest MPC knee, responding 10 to 20 times more rapidly than other MPC knees.
With the most responsive stumble and fall protection, users can instinctively move at their own pace in any direction…even if it’s taking small short steps or pivoting in confined spaces. With a more streamlined, intuitive set up, the Plié 3 MPC Knee makes it even easier for prosthetists to help patients expand their freedom.
The Clinical Commissioning Policy regulates the NHS provision of prosthetic knee components and the decision to approve funding via the NHS for MPKs is aimed to help improve the quality of limb loss rehabilitation for above knee amputees. MPKs will now be funded through Specialised Commissioning by NHS England and will soon be available through Rehabilitation Service Centres to amputees who meet the criteria set out in the policy. With hundreds of amputees living in England with above knee limb loss and hip disarticulation the decision has been welcomed from within the industry.
The new Tred-lite footwear range is a semi-bespoke collection offering a variety of lightweight, comfortable and fashionable solutions for men and ladies. Available in a range of colour, material, strap and sole options, the Tred-lite collection is a perfect match for a variety of patients.
All styles can be manufactured to diabetic specifications, and we even offer a repair and adaptation service for patients’ own footwear. Find out more.
Sepsis affects more than 250,000 people in the UK every year and can be fatal without early detection. However, it is estimated that up to 80% of those patients diagnosed, survive sepsis and most patients who experience this critical illness will return to a normal or a ‘near normal’ life within 18 months.
For over 30 years, we have had a strong presence in Yorkshire, something we are very proud of, and therefore it gives us great pleasure to continue this tradition and announce the opening of our new headquarters in Leeds.